Market Overview

Morning Market Movers

Related PPHM
Earnings Scheduled For July 14, 2015
Peregrine Pharmaceuticals Granted Key European Patent for Its Lead Clinical Drug Candidate Bavituximab
Despite Good News, Peregrine Pharmaceuticals is Hangin' By a Thread (PPHM) (Small Cap Network)
Related EPOC
Benzinga's Volume Movers
athenahealth to Acquire Epocrates for $11.75/Share in Cash

Peregrine Pharmaceuticals (NASDAQ: PPHM) surged 39.26% to $1.88 at 9:45 am. Peregrine Pharmaceuticals provided an update from its internal review of discrepancies from its Phase II second-line non-small cell lung cancer (NSCLC) in 121 patients.

Dialogic (NASDAQ: DLGC) shares advanced 31.34% to $2.39. Dialogic shares have dropped 54.50% over the past 52 weeks, while the S&P 500 index has gained 14.51% in the same period.

Epocrates (NASDAQ: EPOC) surged 21.63% to $11.70. Epocrates agreed to be bought by athenahealth (NASDAQ: ATHN) for $11.75 per share in cash.

RF Industries (NASDAQ: RFIL) climbed 19.56% to $5.3682. For the fourth quarter, RF Industries' preliminary unaudited revenue surged 77% y/y.

Posted-In: Morning Market MoversNews Intraday Update Markets Movers


Related Articles (ATHN + DLGC)

Get Benzinga's Newsletters